# Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

Article · Julien Mazières, Alexander Edward Dela Cruz Drilon, Amélie Lusque, Laurent Mhanna, Alexis Benjamin Cortot, Laura Mezquita, Alesha A. Thai, Céline Mascaux, S. Couraud, Rémi Veillon, Michel M. van den Heuvel, Joel W. Neal, Nir Peled, Martin Früh, Terry L. Ng, Valérie Gounant, Sanjay Popat, Joachim Diebold, Joshua K. Sabari, Viola Weijia Zhu, Sacha I. Rothschild, Paolo Bironzo, Alex Martínez‐Martí, Alessandra Curioni Fontecedro, Rafael Rosell and 13 more

- Archive id: doi:10.1093/annonc/mdz167
- Published: 2019-05-15
- Venue: Annals of Oncology
- DOI: https://doi.org/10.1093/annonc/mdz167
- PMID: 31125062
- Citations: 1,357
- Source URL: https://doi.org/10.1093/annonc/mdz167
- PDF: http://www.annalsofoncology.org/article/S0923753419312840/pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.